New York, NY -- (SBWIRE) -- 12/16/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Hudson City Bancorp, Inc (NASDAQ:HCBK), ReneSola Ltd. (ADR) (NYSE:SOL), Horizon Pharma Inc (NASDAQ:HZNP), BG Medicine, Inc (NASDAQ:BGMD)
Hudson City Bancorp, Inc (NASDAQ:HCBK) showed a volume of 2.80 million shares by the end of last trade whereas the average volume of the stock remained 3.99 million shares. The stock opened the session at $9.17 but then moved to $9.16. Hudson City Bancorp, Inc. (Hudson City Bancorp) serves as the holding company of its subsidiary, Hudson City Savings Bank (the Bank). The Bank is a federal stock savings bank. The Company is a community- and consumer-oriented retail savings bank offering traditional deposit products, residential real estate mortgage loans and consumer loans.
Is HCBK a Solid Investment at These Levels? Read This Report For Details
ReneSola Ltd. (ADR) (NYSE:SOL) opened the session at $2.85 and closed the session at $2.77. The stock showed a negative performance of -1.77% in previous trading session. ReneSola Ltd (ReneSola), incorporated on March 17, 2006, is a global manufacturer of solar wafers and producer of solar power products based in the People's Republic of China. ReneSola possess a global network of suppliers and customers that includes some of the global manufacturers of solar cells and modules. As of December 31, 2012, the Company had an annual wafer manufacturing capacity of approximately 2,000 megawatts,
Has SOL Found The Bottom And Ready To Gain Momentum? Find Out Here
Horizon Pharma Inc (NASDAQ:HZNP) opened the session at $6.79 and closed the session at $6.61. The stock showed a negative performance of -2.07% in previous trading session. Traded with volume of 2.73 million shares in the prior session and the average volume of the stock remained 1.75 million shares. Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Why Should Investors Buy HZNP After the Recent Fall? Just Go Here and Find Out
BG Medicine, Inc (NASDAQ:BGMD) the stock decreased -5.17% and finished the session at $1.10. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a supply agreement with Health Diagnostic Laboratory, Inc.
Will BGMD Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)